本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Catalyst Pharmaceutical Partners

21.03
-0.4200-1.96%
盘后21.470.4400+2.09%19:35 EDT
成交量:123.11万
成交额:2,603.94万
市值:25.65亿
市盈率:13.41
高:21.70
开:21.64
低:20.99
收:21.45
数据加载中...
2024/03/13

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/07

重要事件披露

Form 8-K - Current report
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities